Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows:
- pharmaceutical products (71.5%): prescription drugs in the areas of general medicine (52.7% of net sales; mainly for the treatment of diabetes and cardiovascular diseases) and specialty medicine (47.3%; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases);
- human vaccines (16.7%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas;
- consumer health products (11.8%).
At the end of 2021, the group had 67 production sites throughout the world.
Net sales are distributed geographically as follows: France (6%), Europe (19.8%), the United States (38.1%), China (7.2%), Japan (4.4%), Brazil (2.2%), Russia (1.5%) and other (20.8%).